Project Grant R01GM155100

Award Date 9/1/24
Completion Date 7/31/29
Dollars Obligated $676K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $455,940 to the University of Massachusetts Lowell to study the biophysical properties of intrinsically disordered proteins (IDPs) when confined to nanoscale environments. The research aims to reveal how the structural plasticity of IDPs is influenced by their localization and confinement on nanoparticle constructs, with the...
This $584,420 Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research into spatiotemporal mapping and engineering of the "dark proteome" - intrinsically disordered proteins and their functions. The principal objectives of the grant are to: (1) investigate the role of protein disorder in facilitating transport through the nuclear pore complex, including developing...
The National Institute of General Medical Sciences (NIGMS) awarded a $294,647 Project Grant under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Texas at Dallas (UTD). The grant will fund a 4-year project from September 1, 2024 to August 31, 2028 to develop a theoretical, computational, and experimental framework for modeling epigenetic regulatory networks in human cells. The key objectives are to rapidly assemble and stably integrate libraries of...
This federal Project Grant award of $123,737.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to advance drug discovery for protein domains containing intrinsically disordered regions. The award was granted to the Regents of the University of Michigan, a prominent U.S. state government-owned educational institution, with a performance period from October 1, 2024 to April 30, 2025. The NIGMS...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $275,100 to the University of Colorado-Denver to investigate the role of intrinsically disordered regions (IDRs) in regulating intracellular cargo transport processes. The research aims to: 1) Reveal the mechanistic basis and functional implications of dynein specificity factors, with a focus on the dynein light intermediate...
The Washington University Office of Sponsored Research Services Division has been awarded a $514,876 Project Grant by the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074). The grant will fund a 5-year research project to develop new computational methods for studying the evolution of intrinsically disordered protein regions (IDRs), which play essential biological roles despite not adopting a defined 3D structure. The project aims to identify signatures of...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $585,000 in funding to the University of Texas at Dallas (UTD) for the period of August 1, 2025 to May 31, 2030. The grant supports two key objectives: Developing innovative strategies and platforms for discovering 'natural product'-like macrocyclic peptides as potent and selective modulators of biomolecular interactions. This...
The National Institute of General Medical Sciences (NIGMS) awarded a $460,413 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to the University of Texas at Dallas (UTD) on April 22, 2025. The goal of this 4.7-year project is to develop a novel visible light-induced transition metal-radical hybrid catalytic methodology for regiocontrolled, mild, and exogenous oxidant-free functionalization of saturated organic groups. This research aims to create a new synthetic platform...
The National Institute of General Medical Sciences (NIGMS) awarded a $243,840 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Pittsburgh. The project, titled "An Effective Statistical Inference Framework to Develop Innovative Compensations for Protein Mutations," aims to develop quantitative methods for predicting the impact of protein mutations and identifying compensatory mutations that can restore normal protein...
This Project Grant award of $562,800.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports research to determine whether pseudoenzymes from various enzyme superfamilies exhibit catalytic activity and potentially catalyze novel chemical transformations. The research aims to uncover unexpected post-translational modifications for pseudoenzymes, which could yield vital mechanistic insights into disease...

The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training federal grant program (CFDA 93.859), awarded a $675,898 Project Grant to The University of Texas Southwestern Medical Center (UT Southwestern) to conduct research on defining the modular architecture of protein intrinsically disordered regions (IDRs) for a predictive understanding of biological function. The 5-year grant, starting on Sep 1, 2024, will use computational approaches, in vitro experiments, and in vivo studies to comprehensively classify IDRs, develop predictive models of IDR function, and delineate how the modular architecture of disordered sequences impacts their conformation and function. This research aims to provide a new level of interpretability and predictability in understanding the functional mechanisms of IDRs, which are a class of protein sequences that do not adopt stable secondary structures.

Generated 8/5/25, 3:05 AM